Which vaccines will curb the Ebola outbreak? WHO debates
The WHO is currently debating which vaccines and therapeutics should be tested to combat the ongoing Bundibugyo Ebola outbreak in the Democratic Republic of the Congo. There are no approved vaccines for this specific strain, prompting experts to suggest clinical trials for potential treatments. The U.S. has decided not to bring Ebola patients back for treatment, opting instead to evacuate them to Europe, which has raised concerns among health experts.
- ▪The WHO is considering various drugs and vaccines to address the Bundibugyo Ebola outbreak.
- ▪There are currently no approved vaccines or therapeutics for the Bundibugyo species of Ebola.
- ▪The U.S. will not treat Ebola patients domestically, opting for evacuation to Europe instead.
Opening excerpt (first ~120 words) tap to expand
NewsletterMorning Rounds Which vaccines will curb the Ebola outbreak? WHO debates The growing Ebola outbreak, the unknowns of microdosing GLP-1s, and more health news from Morning Rounds Manage alerts for this article Email this article Share this article SAIDU BAH/AFP via Getty Images By O. Rose BroderickMay 29, 2026 Disability in Health Care Reporting Fellow O. Rose Broderick[email protected]Rose covers disability and mental health, and she helps write STAT’s daily Morning Rounds newsletter. Confidential tips can be sent to Rose on Signal at rosebroderick.11. Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Another Morning Rounds, another double feature from STAT’s Helen Branswell.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at STAT News.
Discussion
0 commentsMore from STAT News
